Ruling Over Serevent In Glaxo's Favor Will Stand

Law360, New York (November 30, 2007, 12:00 AM EST) -- A federal court’s finding of summary judgment for SmithKline Beecham Corp. in a case involving the death of a user of the pharmaceutical company’s asthma drug Serevent will stand, after a judge declined to reconsider his earlier ruling in the case.

Judge Stephen McNamee of the U.S. District Court for the District of Arizona on Tuesday denied the plaintiffs’ motion for reconsideration of his Sept. 5 summary judgment order.

In that order, the judge found that the plaintiffs, the mother and child of a man who...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.